Cumberland Pharmaceuticals (CPIX) Cash & Equivalents Growth (3y) (2013 - 2026)
Cumberland Pharmaceuticals (CPIX) Cash & Equivalents Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | 21.81% |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.33 Bn | 2.15 Bn | 11.05% |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | -4.92% |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 7.80% |
| 5 | United Therapeutics | 22.15 Bn | 19.48 Bn | 683.80 Mn | 19.10% |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 12.11% |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn | 27.55% |
| 8 | Elanco Animal Health | 11.74 Bn | 11.21 Bn | 798.00 Mn | 13.03% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | 32.82% |
| 10 | Cumberland Pharmaceuticals | 116.56 Mn | 112.69 Mn | - | -40.41% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -40.41% |
| Mar 31, 2026 | -12.42% |
| Dec 31, 2025 | -16.64% |
| Sep 30, 2025 | -8.04% |
| Jun 30, 2025 | -4.06% |
| Mar 31, 2025 | -4.35% |
| Dec 31, 2024 | -12.74% |
| Sep 30, 2024 | -12.24% |
| Jun 30, 2024 | -12.26% |
| Mar 31, 2024 | -9.38% |
| Dec 31, 2023 | -9.54% |
| Sep 30, 2023 | -11.44% |
| Jun 30, 2023 | -12.64% |
| Mar 31, 2023 | -15.36% |
| Dec 31, 2022 | -11.20% |
| Sep 30, 2022 | -10.19% |
| Jun 30, 2022 | -4.56% |
| Mar 31, 2022 | -11.14% |
| Dec 31, 2021 | -1.08% |
| Sep 30, 2021 | -12.26% |